RETATRUTIDE 10mg

Sold out
RETATRUTIDE 10mg
A$170.00

Documentation: Batch-specific Certificates of Analysis (COAs) are included within the product image gallery for reference.

 


FOR RESEARCH USE ONLY 

Intended Use: This product is supplied strictly for laboratory research use only. Not for human or veterinary use.

 



Retatrutide is a synthetic peptide under investigation as a metabolic modulator, designed to act as a multi-receptor agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. These receptors are involved in the physiological regulation of glucose homeostasis, appetite, and energy metabolism.

 

Retatrutide has been evaluated primarily in non-clinical studies and early-phase clinical investigations for its potential effects on body weight, glycaemic control, and metabolic parameters. At present, retatrutide is not included on the Australian Register of Therapeutic Goods (ARTG) and is not approved by the Therapeutic Goods Administration (TGA) for the prevention, diagnosis, treatment, or cure of any disease or medical condition.

 

Technical Specifications - RETATRUTIDE 10 mg

 

  • Name: Retatrutide (also known as LY3437943; investigational multi-agonist peptide)
  • Classification: Long-acting peptide agonist targeting GLP-1, GIP, and glucagon receptors (triple-agonist)
  • Sequence: Proprietary synthetic peptide sequence designed for receptor co-agonism (exact sequence not publicly disclosed by the developer)
  • Molecular Weight: Approx. ~4–5 kDa (range based on publicly available research data; exact mass varies by salt form and is not officially published)
  • Molecular Formula: Not fully disclosed in public research-grade listings; varies by analogue and salt form
  • CAS Number: 2907286-09-9 (associated with retatrutide in public chemical registries)
  • Physical Form: Lyophilized (freeze-dried) white to off-white peptide powder (research-grade)
  • Purity: Research suppliers typically list ≥ 98–99% purity (HPLC verified)
  • Solubility:
    • Soluble in sterile water for in-vitro laboratory use
    • May require gentle agitation for full dissolution
    • Soluble in mild aqueous buffers and some dilute acidified solvents as commonly used in peptide research
  • Storage / Handling:
    • Before reconstitution: Store at –20 °C or colder, protected from light and moisture
    • After reconstitution: Store at 2–8 °C and use promptly
    • Avoid repeated freeze–thaw cycles; bring vial to room temperature before opening to prevent condensation
  • Intended Application:
    Labeled Research Use Only (RUO). Intended for in-vitro, biochemical, or laboratory-based receptor and metabolic studies.
    Not approved for human or veterinary therapeutic administration.
  • General Notes:
    Retatrutide is an investigational tri-agonist peptide extensively studied for metabolic and endocrine research applications. Published clinical-trial data suggest potent multi-receptor activation; however, safety, long-term outcomes, and therapeutic viability remain under investigation. Human use is restricted to controlled clinical research with appropriate approvals.


Product Disclaimer


This product is supplied for laboratory research use only. It has not been approved by any national regulatory authority (including the FDA, EMA, or Australian TGA) for human therapeutic, diagnostic, or veterinary use. The purchaser assumes all responsibility for the handling, storage, and disposal of this material in accordance with applicable institutional, local, and national regulations.

 

The manufacturer/distributor makes no claims regarding the safety, efficacy, or suitability of this material for any medical application or human administration. This product should not be ingested, injected, or otherwise administered to humans or animals except within the context of an approved clinical trial using appropriate GMP-grade material and regulatory approvals.

 

This product should be handled only by qualified personnel trained in laboratory safety and in the handling of research reagents. Keep out of reach of children. Improper use may cause harm. The product is supplied “as is”, and no warranty, express or implied, is made regarding fitness for a particular purpose. Individual results may vary. The purchaser should review available safety data and consult institutional safety officers prior to use.